Stay updated with breaking news from Caredx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc (NASDAQ:CDNA – Get Rating) insider Reginald Seeto sold 2,818 shares of CareDx stock in a transaction on Monday, April 3rd. The shares were sold at an average price of $8.95, for a total transaction of $25,221.10. Following the completion of the transaction, the insider now owns 537,815 shares in the company, valued at […]
CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given an average recommendation of “Hold” by the six brokerages that are covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among […]
Jounce Therapeutics said on Monday that it was ditching a planned merger with AIM-listed Redx Pharma, opting instead to be bought by Concentra Bioscences.
06.03.2023 - CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company ...
Lazard Asset Management LLC raised its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 46.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,738 shares of the company’s stock after purchasing an additional 2,448 shares during the quarter. Lazard Asset Management LLC’s holdings […]